catechin has been researched along with thromboxane b2 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WC; Hsu, FL | 1 |
| Liu, JM; Lou, FQ; Yuan, WL; Zhang, MF; Zhang, XG | 1 |
| Etherton, TD; Kris-Etherton, PM; Lazarus, SA; Proch, J; Vinson, JA; Wan, Y | 1 |
| Gendron, ME; Thorin, E | 1 |
| Gao, S; Hou, R; Liang, R; Wang, L; Yan, R; Yang, B; Zhang, J | 1 |
| Altavilla, D; Arcoraci, V; Bitto, A; Galfo, F; Irrera, N; Macrì, A; Minutoli, L; Pallio, G; Pizzino, G; Squadrito, F; Squadrito, G | 1 |
1 trial(s) available for catechin and thromboxane b2
| Article | Year |
|---|---|
Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Antioxidants; Biflavonoids; Biological Availability; Cacao; Candy; Catechin; Cholesterol, LDL; Cross-Over Studies; Female; Flavonoids; Humans; Male; Middle Aged; Oxidation-Reduction; Phenols; Pilot Projects; Polymers; Powders; Proanthocyanidins; Prostaglandins; Theobromine; Thromboxane B2 | 2001 |
5 other study(ies) available for catechin and thromboxane b2
| Article | Year |
|---|---|
Inhibition of platelet activation and endothelial cell injury by flavan-3-ol and saikosaponin compounds.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catechin; Cattle; Cells, Cultured; Endothelium, Vascular; Flavonoids; Humans; Hydrogen Peroxide; Oleanolic Acid; Platelet Aggregation; Platelet Aggregation Inhibitors; Sapogenins; Saponins; Thromboxane B2 | 1991 |
A study on tea-pigment in prevention of atherosclerosis.
Topics: Animals; Anticoagulants; Arteriosclerosis; Blood Coagulation; Catechin; Male; Muscle, Smooth, Vascular; Pigments, Biological; Platelet Aggregation Inhibitors; Rabbits; Tea; Thromboxane B2 | 1989 |
A change in the redox environment and thromboxane A2 production precede endothelial dysfunction in mice.
Topics: Acetylcholine; Acetylcysteine; Aging; Animals; Antioxidants; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Catechin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Unsaturated; Gene Expression Regulation, Enzymologic; Hydrazines; Indomethacin; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroarginine; Oxidation-Reduction; Reactive Oxygen Species; Receptors, Thromboxane A2, Prostaglandin H2; Renal Artery; RNA, Messenger; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Vasodilator Agents | 2007 |
Effects of an aqueous extract of Crataegus pinnatifida Bge. var. major N.E.Br. fruit on experimental atherosclerosis in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Atherosclerosis; Biflavonoids; C-Reactive Protein; Catechin; Chlorogenic Acid; Crataegus; Diet, High-Fat; Drugs, Chinese Herbal; Endothelins; Fruit; Interleukins; Lipids; Male; Nitric Oxide; Plant Extracts; Proanthocyanidins; Quercetin; Random Allocation; Rats; Rats, Wistar; Rutin; Thromboxane B2; Water | 2013 |
Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Body Weight; Catechin; CD3 Complex; Celecoxib; Colitis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Combinations; Eating; Gene Expression Regulation; Hydroxyurea; Leukotriene B4; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Neutrophil Infiltration; Rats; Rats, Sprague-Dawley; Thromboxane B2; Tumor Necrosis Factor-alpha | 2016 |